BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 8884963)

  • 1. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy.
    Johansen J; Bentzen SM; Overgaard J; Overgaard M
    Radiother Oncol; 1996 Aug; 40(2):101-9. PubMed ID: 8884963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a positive correlation between in vitro radiosensitivity of normal human skin fibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy.
    Johansen J; Bentzen SM; Overgaard J; Overgaard M
    Int J Radiat Biol; 1994 Oct; 66(4):407-12. PubMed ID: 7930844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer.
    Brock WA; Tucker SL; Geara FB; Turesson I; Wike J; Nyman J; Peters LJ
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1371-9. PubMed ID: 7635777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity.
    Bentzen SM; Overgaard M; Overgaard J
    Eur J Cancer; 1993; 29A(10):1373-6. PubMed ID: 8398261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up.
    Turesson I; Thames HD
    Radiother Oncol; 1989 Jun; 15(2):169-88. PubMed ID: 2762590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients.
    Geara FB; Peters LJ; Ang KK; Wike JL; Brock WA
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1173-9. PubMed ID: 8262844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of correlation of human fibroblast radiosensitivity in vitro with early skin reactions in patients undergoing radiotherapy.
    Begg AC; Russell NS; Knaken H; Lebesque JV
    Int J Radiat Biol; 1993 Oct; 64(4):393-405. PubMed ID: 7901301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and late toxicity, tumour control and intrinsic radiosensitivity of primary fibroblasts in vitro of patients with advanced head and neck cancer after concomitant boost radiochemotherapy.
    Rudat V; Dietz A; Nollert J; Conradt C; Weber KJ; Flentje M; Wannenmacher M
    Radiother Oncol; 1999 Dec; 53(3):233-45. PubMed ID: 10660204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between early and late normal-tissue injury after postmastectomy radiotherapy.
    Bentzen SM; Overgaard M
    Radiother Oncol; 1991 Mar; 20(3):159-65. PubMed ID: 1852907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal tissue radiosensitivity in breast cancer patients.
    Ramsay J; Birrell G
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):339-44. PubMed ID: 7836087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low predictive value of intrinsic fibroblast radiosensitivity for fibrosis development following radiotherapy for breast cancer.
    Russell NS; Grummels A; Hart AA; Smolders IJ; Borger J; Bartelink H; Begg AC
    Int J Radiat Biol; 1998 Jun; 73(6):661-70. PubMed ID: 9690684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.
    Póti Z; Nemeskéri C; Fekésházy A; Sáfrány G; Bajzik G; Nagy ZP; Bidlek M; Sinkovics I; Udvarhelyi N; Liszkay G; Repa I; Galuska L; Trón L; Mayer A; Esik O
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1022-33. PubMed ID: 15001241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro radiosensitivity of skin fibroblasts can identify a group of patients with complications in various health tissues after radiotherapy].
    Alsbeih G; Malone S; Grimard L; Raaphorst GP
    Cancer Radiother; 1999; 3(4):318-24. PubMed ID: 10486543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors for late normal tissue complications following radiotherapy for breast cancer.
    Lilla C; Ambrosone CB; Kropp S; Helmbold I; Schmezer P; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Chang-Claude J
    Breast Cancer Res Treat; 2007 Nov; 106(1):143-50. PubMed ID: 17221151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between normal tissue complications and in vitro radiosensitivity of skin fibroblasts derived from radiotherapy patients treated for variety of tumors.
    Alsbeih G; Malone S; Lochrin C; Girard A; Fertil B; Raaphorst GP
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):143-52. PubMed ID: 10656386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between DNA double-strand breaks, cell killing, and fibrosis studied in confluent skin fibroblasts derived from breast cancer patients.
    Dikomey E; Brammer I; Johansen J; Bentzen SM; Overgaard J
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):481-90. PubMed ID: 10661357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer.
    Barber JB; Burrill W; Spreadborough AR; Levine E; Warren C; Kiltie AE; Roberts SA; Scott D
    Radiother Oncol; 2000 May; 55(2):179-86. PubMed ID: 10799730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wound healing morbidity in STS patients treated with preoperative radiotherapy in relation to in vitro skin fibroblast radiosensitivity, proliferative capacity and TGF-beta activity.
    Akudugu JM; Bell RS; Catton C; Davis AM; Griffin AM; O'Sullivan B; Waldron JN; Ferguson PC; Wunder JS; Hill RP
    Radiother Oncol; 2006 Jan; 78(1):17-26. PubMed ID: 16380182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation state of skin fibroblast cultures versus risk of subcutaneous fibrosis after radiotherapy.
    Herskind C; Bentzen SM; Overgaard J; Overgaard M; Bamberg M; Rodemann HP
    Radiother Oncol; 1998 Jun; 47(3):263-9. PubMed ID: 9681889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro cellular radiosensitivity in relationship to late normal tissue reactions in breast cancer patients: a multi-endpoint case-control study.
    Vandevoorde C; Depuydt J; Veldeman L; De Neve W; Sebastià N; Wieme G; Baert A; De Langhe S; Philippé J; Thierens H; Vral A
    Int J Radiat Biol; 2016 Dec; 92(12):823-836. PubMed ID: 27586010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.